Single-cell genome analyses of human oocytes are important for meiosis research and preimplantation genomic screening. However, the nonuniformity of single-cell whole-genome amplification hindered its use. Here, we demonstrate genome analyses of single human oocytes using multiple annealing and looping-based amplification cycle (MALBAC)-based sequencing technology. By sequencing the triads of the first and second polar bodies (PB1 and PB2) and the oocyte pronuclei from same female egg donors, we phase the genomes of these donors with detected SNPs and determine the crossover maps of their oocytes. Our data exhibit an expected crossover interference and indicate a weak chromatid interference. Further, the genome of the oocyte pronucleus, including information regarding aneuploidy and SNPs in disease-associated alleles, can be accurately deduced from the genomes of PB1 and PB2. The MALBAC-based preimplantation genomic screening in in vitro fertilization (IVF) enables accurate and cost-effective selection of normal fertilized eggs for embryo transfer.
INTRODUCTION
Successful human sexual reproduction starts with meiosis of an oocyte, which, upon fusion with a sperm cell, results in a fertilized egg whose viability is crucial to producing a healthy neonate. At the onset, every human oocyte undergoes homologous recombination of paternal and maternal genomes, which generates crossovers in individual chromosomes, contributing to genetic diversity in human evolution. Hence, each human germ cell has a unique genome, necessitating single-cell sequencing analyses, which have been recently achieved in sperm (Wang et al., 2012; Lu et al., 2012) .
A normal male's sperm cell has 3%-4% probability of aneuploidy (Hunt and Hassold, 2002) , chromosome abnormality due to their segregation errors, and this percentage may not change much with age (Fonseka and Griffin, 2011) . Sperm cells with such aneuploidy would result in miscarriage or genetic disorders (Ferguson et al., 2007) . However, aneuploidy occurs with much higher probability for the female counterpart, an oocyte, and increases drastically with the age of the female, which is one of the major causes of the decreasing live birth rate over time (Qiao et al., 2013) .
Primary oocytes (four sets of chromatids, 4C) finish homologous recombination during a female's fetal period and enter a more than 10 year arrest at meiosis I. After puberty, in every menstrual cycle, one of the primary oocytes undergoes cell division, extrudes a diploid first polar body (PB1), and becomes a secondary oocyte arresting at meiosis II ( Figure 1A ). Upon its fertilization with a sperm cell, the secondary oocyte extrudes a haploid second polar body (PB2), and the remaining fertilized egg contains a haploid female pronucleus (FPN), as well as a haploid male pronucleus (MPN) ( Figure 1B) .
It is reported that crossovers in human oocytes have a frequency 1.73 higher than that of sperm (Broman et al., 1998) . However, the majority of previous human oocyte crossover studies have relied on genetic linkage analyses based on family pedigree, which could be under the influence of selection. Although cytological assays of homologous recombination in the human oocytes have allowed analysis of the crossover number and distribution at the single-cell level, the resolution was relatively low (Cheng et al., 2009) . Using single-cell wholegenome sequencing analyses, we have carried out the first detailed study of recombination at high resolution on human oocyte meiosis, free from the above complications.
Crossover interference along the genome has been implicated by the nonrandomly distributed crossovers (Fung et al., 2004; Jeffreys et al., 1998) . Sequencing a large number of sperm cells from a person has enabled identification of individual specific recombination distribution in males Wang et al., 2012) , but the counterpart sequencing analysis for oocyte crossover interference has not been carried out yet. Another type of genetic interference is chromatid interference, which refers to the phenomenon that the selection of a nonsister chromatid pair for a crossover is not random but rather is affected by whether the chromatids are involved in a neighboring crossover. We (B) Flowchart of experiment procedures. The first and second polar bodies, dispensable for embryo development, were safely biopsied by a micropipette, followed by single-cell lysis, MALBAC amplification, and high-throughput sequencing. See also Figure S1 . have resolved these issues by simultaneously sequencing the triad of the first and second polar bodies and the female pronucleus.
MALBAC amplificaƟon
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This (Treff et al., 2013; Liss et al., 2011) . Here, we report the single-cell genomic studies on donated human oocytes, which were not transferred into any of the participants. Single-cell wholegenome amplification has offered high genome coverage with much reduced sequence-dependent bias. With the high coverage of MALBAC, we show that the genome of the FPN, information regarding aneuploidy, and SNVs in diseaseassociated alleles in particular can be accurately deduced from the genomes of PB1 and PB2 if the genetic disorders are from the mother. If the genetic disorders are from the father, one can sequence one or a few cells from the blastocyst stage of the embryo. We demonstrate that whole-genome analyses of single human oocytes based on MALBAC allow accurate and cost-effective embryo selection for in vitro fertilization.
RESULTS
Single-Cell Whole-Genome Amplification and Sequencing of Polar Bodies and Female Pronuclei We recruited eight healthy voluntary Asian female donors, who are 25-35 years old and have one or two healthy children from natural pregnancy, with their signed informed consent documents. The oocytes were collected using standard clinical protocols and then fertilized by intracytoplasmic sperm injection (ICSI). In total, we obtained 70 fertilized oocytes, on average 8.8 oocytes (4-15) per donor ( Figure 2A) .
The first and second polar bodies, as well as the female pronuclei of egg cells, were isolated with laser-assisted micromanipulation ( Figure S1 available online). PB1 and PB2 were successfully biopsied from 67 (95.7%) and 64 (91.4%) oocytes, respectively. For verification purpose, the FPN of 52 (74.3%) oocytes have been biopsied. In total, 183 single cells were successfully isolated. The genome of each single cell was amplified by MALBAC and was sequenced at 0.73 depth on HiSeq 2000 ( Figure 1B ), obtaining genome coverage of $32% for each single cell on average ( Figure S2A and Table S1 ).
SNP Calling and Phasing of the Donor's Genome
We determined the heterozygous SNPs (hetSNPs) for a donor using the single-cell sequencing data of all her donated oocytes instead of sequencing the donor's blood DNA. In this study, combining sequencing data of all oocytes available from the same individual, for whom the overall sequencing depth varied from 43 to 373, allows us to achieve individual genome coverage of 70% to 97% (Figure 2A) .
Using an algorithm similar to that of population SNP calling (Bansal et al., 2010) and following a set of stringent filtering measurements, we determined 330,000-1,386,000 hetSNPs for each donor, approximately in proportion with the overall sequencing depth. Employing the donor's hetSNP information, we determined the alleles carried by each single cell at these SNP loci . On average, 180,000-670,000 highconfidence SNPs were determined for a single cell of each donor, which generally accounts for half of the donor's total hetSNPs.
To determine the haplotype from a donor's hetSNPs, we primarily exploited the haploid PB2 cells of the oocytes. Two independent algorithms were implemented, and the results from them were comparable, thus verifying the phasing accuracy (Figures 2B and S2B) (Kirkness et al., 2013; Lu et al., 2012) . We confidently phased the haplotype on 91%-95% hetSNP loci for each donor at the whole-chromosome level. Then, crossovers on each chromosome of every individual cell were successfully inferred with the phased haplotype using a hidden Markov model (HMM) ( Figures 2C, S2C , and S2D).
Female Personal Genetic Map Construction
For all donors, we identified 2,370 and 2,355 crossovers in PB2 and FPN of 55 euploid oocytes, respectively (Table S1 ). The average of 43 crossovers per haploid cell is $1.653 of that in sperm. This phenomenon has been shown previously in mice that oocytes have a frequency 1.33 higher than that of sperm (Petkov et al., 2007) .
These sex-specific differences likely result entirely from differences in longitudinal chromosome organization (Kleckner et al., 2003) . At leptotene, chromosomes develop into a synaptonemal complex (SC), an array of chromatin loops whose bases, elaborated by proteins, comprise a longitudinal structural axis. The number of loops per micrometer of SC is relatively fixed for different sexes, regardless of the loop size. Females exhibit longer SCs than males (Tease and Hulté n, 2004) . Thus, female chromosomes will be organized into more loops of smaller average size (Kleckner, 2006; Novak et al., 2008) . Further, recombination initiation complexes develop in association with loop bases (Panizza et al., 2011) . Thus, females will have more initiation complexes and more initiating double-strand breaks (DSBs). Such proportionality of DSB number to chromosome length has been demonstrated in C. elegans (Mets and Meyer, 2009) . DSBs develop into interhomolog interactions which, in turn, are operated upon by crossover interference. The number of crossovers is proportional to both the number of DSBs and to physical chromosome length. Proportionality of CO number and SC length has long been known for male and female in human and in other species (Kleckner et al., 2003; Tease and Hulté n, 2004) .
A moderate correlation (R = 0.61) was observed between the crossover numbers in the PB2 and FPN from the same oocyte ( Figure 3B ). Overall, crossovers do not show significant preference for FPN over PB2 in meiosis (paired Student's t test p value 0.80 and F test p value 0.79), indicating that there is no significant relationship between the haploid cell fate in meiosis II and the crossover numbers in its genome.
By binning the crossovers into 5 Mb units in the genome, we constructed the first set of female personal genetic maps, which are largely consistent with the sex-averaged map based on population analysis (HapMap) (Myers et al., 2005) and a female-specific map based on pedigree analysis (deCODE) (Kong et al., 2010) on the megabase scale ( Figure 3C ). Notably, chromosome X-X recombination of an individual can be analyzed by sequencing for the first time, which gave a personal chromosome X recombination rate ranging from 1.01 to 1.18 centimorgan (cM) per Mb, which is similar to the recombination pattern of autosomes (Tables S2 and S3 ). However, limited by the small number of oocytes for each donor, it is not feasible to detect personal recombination hot spots with statistical significance. By merging eight donors' personal genetic maps, we obtained a population genetic map that is comparable to deCODE map ( Figure S3A and Table S4 ).
The improved amplification evenness of MALBAC allowed us to achieve high resolution in detecting crossovers with low sequencing depth ( Figure 3D ). About 95%, 84%, and 55% of the crossovers could be confidently assigned to intervals of 200, 100, and 30 kb, respectively. With this high resolution, we were able to study the crossover distributions at a finer genome scale. We observed a drop of recombination rates in oocyte data close to the transcription start site (TSS) (Figure 3E ), reinforcing the speculation that the variation of recombination probability during oocyte meiosis, rather than selection, gives rise to the See also Figure S2 and Table S1 . Number of gametes (or oocytes)
Crossover number reduced recombination rate close to TSS (Coop et al., 2008) . Of the crossovers unambiguously resolvable within a 10 kb interval, $44% of these crossover intervals overlapped with at least one PRDM9 binding motif (CCnCCnTnnCCnC), which is consistent with the recently published study on single sperm cells and previous population studies (Myers et al., 2008) .
Crossover Interference in Human Oocytes Compared with Sperm
Crossover interference is a phenomenon that a chromosomal crossover at one position decreases the probability for another crossover occurring nearby. Crossover interference in human sperm has been recently observed by single-sperm cell sequencing Wang et al., 2012) . Here, we report our study of crossover interference in single human oocytes. We used coefficient of coincidence (CoC) to describe the strength of interference. This approach considers the magnitude of crossover interference as a function of the distance between crossovers along a chromosome. It provides a chromosomewide view, irrespective of nonuniform recombination rate along the genome (Petkov et al., 2007) . Figure 3F shows the CoC for the crossover interference of oocyte as a function of genetic distance (number of base pairs), as compared with that for human sperm . It is evident that interference acts over a smaller number of base pairs in oocytes than in sperm, which is consistent with the fact that oocytes have more crossovers per chromosome. Furthermore, the CoC curve of the neighboring crossovers on the same arms of chromosomes shows no significant difference from that of all crossovers, verifying that the crossovers across centromeres do not affect the CoC values calculated ( Figure S3B ). Further analysis reveals, however, that when we plot the CoC as a function of the physical distance of the SC length (which is longer in oocytes than in sperm), the sperm and oocyte's curves overlap ( Figure S3C ). Analogous results have also been found in mouse (Petkov et al., 2007) and Arabidopsis (Drouaud et al., 2007) . Crossover interference involves the spreading of an inhibitory signal along well-organized chromosomes. The fact that CoC curves for oocyte and sperm overlap when SC length is used as a metric has two mechanistic implications. First, the metric for the spreading interference signal is physical distance along the chromosome, not genomic distance in DNA/base pair length. Second, the strength of interference, i.e., the distance over which the inhibitory signal acts along the chromosomes, is exactly the same in human oocytes and spermatocytes.
Crossover interference happens between neighboring crossovers in the four sets of chromatids within the oocyte, whereas a haploid PB2 or FPN only has half of the total number of crossovers in the oocyte. We counted the crossovers of PB1, PB2, and FPN derived from the same oocyte and found that each oocyte has an average of 76 crossovers (88% of the theoretical value 43 3 2) (Table S2) , and the distribution of the distance between two adjacent crossovers is shown in blue in Figure 3G . These triad data in oocytes capture more crossovers than the data from PB2 and FPN alone with only an average of 43 crossovers, providing better statistics for human oocyte crossover interference, yielding a shorter distance between two adjacent crossovers.
Weak Chromatid Interference in Human Oocytes
Another type of genetic interference, chromatid interference, refers to the phenomenon that the selection of a nonsister chromatid pair in one crossover influences the chromatid selection for a neighboring crossover (Zhao et al., 1995) . Unlike the crossover interference, chromatid interference has been less studied, and the reported results are inconsistent (Chen et al., 2008; Speed et al., 1992; Teuscher et al., 2000) . With the meiosis triad data here, we were able to study chromatid interference by identifying which nonsister chromatid pair is involved in each crossover. Considering the anchoring effect of centromeres, the crossover pairs were counted on the same or different chromosome arms separately.
On the same arm of a chromosome, the two crossovers nearest to the centromere exhibit four different categories denoted as two chromatids, three chromatids (I), three chromatids (II), and four chromatids ( Figure 3H ). In our experiment, three out of the four categories can be distinguished and counted, whereas one category, three chromatids (I), cannot be identified because crossovers between the two chromatids are not recognizable in the diploid PB1. The theoretical ratio of the three identifiable categories should be 1:1:1 in the absence of chromatid interference. As shown in Figure 3H , a total count of 440 (35% ± 1%), 440 (35% ± 1%), and 374 (30% ± 1%) was observed for the two chromatids, three chromatids (II), and four chromatids categories, respectively, indicating that there is a weak and negative chromatid interference in human meiosis (H) Weak negative chromatid interference within the same chromosome arm. There are four possible recombination categories for chromatid pair selection in a crossover, considering a neighboring crossover on the same chromosome arm. The numbers for each recombination category are counted from the crossover pairs nearest to the centromere in the 55 euploid oocytes. The ratio of the three categories is 35 (± 1%): 35 (± 1%): 30 (± 1%), not 1:1:1, suggesting that there is a negative chromatid interference. See also Figure S3 and Tables S2, S3 , and S4.
(chi-square test, p value 0.03). The positive interference means that having the first crossover between a pair of chromatids decreases the probability of having another crossover between the second pair containing one of the two original chromatids. The negative interference means the reverse. The slight but negative interference is confirmed by our bootstrapping analysis (Figure S3D) , which yields the error bars. We note that weak chromatid interference was reported for fungus N. crassa, whereas no chromatid interference was reported for yeast (Mancera et al., 2008; Zhao et al., 1995) . We are aware of the complications that differences might exist among chromosomes and various genome regions. The weak chromatid interference in human oocytes seen in our experiment calls for further investigations on the underlying mechanism.
In contrast, for crossover pairs on different chromosome arms, only two observable patterns can be identified (Figure S3E) . One pattern contains the two chromatids and three chromatids (I) category, whereas the other pattern contains the four chromatids and three chromatids (II) category. We observed an almost equal count, 478 (50%) and 477 (50%), for the two observable patterns, respectively (chi-square test, p value 0.97), the bootstrapping of which was shown in Figure S3F . These results suggest that chromatid interference does not exist when the two crossovers are on the opposite sides of a centromere.
Allele Deduction of a Female Pronucleus by Sequencing the First and Second Polar Bodies
It is highly desirable to determine which sets of alleles are present in an FPN due to homologous recombination without destroying the FPN. In principle, with the knowledge of the donor's haplotypes, the FPN alleles can be easily deduced from those of PB1 and PB2. This deduction is based on the fact that there should be a total of two copies of both paternal and maternal DNA when summing up the PB1, PB2, and FPN from the same oocyte ( Figures 4A and 4B ). Based on this principle, we can deduce the alleles of an FPN by sequencing its two corresponding polar bodies, which facilitates genome-wide screening of maternal disease-associated alleles in the FPN.
To demonstrate the proof of principle, we sequenced FPNs under the donors' consents and compared it with the deductions from the two corresponding polar bodies. Indeed, 91% of the predicted haplotypes for FPN, 40 out of 44, were confirmed by direct sequencing of the FPNs (Figures 4C and S4 ). Among the unmatched four oocytes, three have severe DNA degradation in PB1, and one has intrinsic chromosome abnormality (discussed below). When the haplotype of an FPN is determined, all the phased SNPs of the donor are allocated to FPN (Figure 4B) . In so doing, the density of predicted alleles for the FPN depends solely on the donor's phased hetSNPs, which can be further improved by other SNP discovering and phasing techniques (Wang et al., 1998) , enabling high-accuracy and high-density SNP prediction without destroying the FPN.
Identification of Maternal Mendelian Diseases by MALBAC-Based Genome-wide PGS About 7,000 monogenic disorders have been estimated (Boycott et al., 2013) , which in total occur in about 1 out of every 200 neonates. Usually, every individual carries some heterozygous disease-associated alleles (Abecasis et al., 2012) . If this allele is dominant, it is desirable to avoid transmission of this maternal allele to the neonate. If the disease-associated allele is recessive, it is also desirable to avoid transmission of this maternal allele to the neonate in case the father also carries and contributes the disease allele to the baby.
PGD for Mendelian diseases can greatly reduce genetic defects (Sermon et al., 2004) . The most widely adopted method for detecting known disease-associated alleles is blastomere biopsy coupled with single-locus PCR (Van de Velde et al., 2000) . However, PCR-based PGD can detect only limited numbers of suspected loci due to its low throughput. With the predicted SNPs, we can thoroughly screen undesirable alleles in FPN, which were associated with severe hereditary genetic diseases.
Among the eight donors' heterozygous SNV alleles, we found several potential disease-associated alleles for each donor (Table S5 ) using the Human Gene Mutation Database (HGMD). Taking donor S08 as an example, we identified three potential disease-associated alleles in genes AGL, GP9, and HPD (Table 1) .
Although these diseases are not severe, they provide hypothetical test cases for the ability to call SNVs for embryo selection. In principle, the oocytes containing fewer Mendelian disease-associated alleles can be selected for embryo transfer. We confirmed the predicted alleles by Sanger sequencing of the MALBAC product of the 11 female pronuclei under the donor's consent (Table 1 and Figure S5 ). For 32 out of 33 loci, Sanger sequencing results were consistent with the predictions, except the one not successfully amplified by MALBAC, and were not able to be analyzed by Sanger sequencing. Overall, this result confirmed the feasibility of detecting and avoiding genome-wide maternal Mendelian disease-associated alleles in fertilized eggs.
Detection of Aneuploidy in Oocytes with High Accuracy and Resolution
Aneuploidy, abnormality of chromosome numbers due to chromosome segregation errors during meiosis, results in miscarriage or genetic disorders of neonates. In PGS, CGH and SNP arrays have been used for aneuploidy screening (Harper and Sengupta, 2012) but with limited resolution. With MALBAC's significantly improved coverage uniformity over other existing whole-genome amplification methods , the aneuploidy can be confidently determined with the raw coverage depth for an individual oocyte ( Figure 5A ). Moreover, we found that MALBAC's systematical coverage bias on a finer scale is reproducible genome wide and can be normalized in order to further reduce the bias (Figures S6A and S6B ). Using the normalized coverage depth, the copy number can be accurately determined at a megabase resolution ( Figure 5A ).
In order to measure the signal stability, the SD of normalized coverage depth for each cell was calculated. Most (97%) of the cells showed only slight bias of coverage depth (SD < 0.36) except for six (3%) cells (SD > 0.36), including three PB1, one PB2, and two FPN ( Figure 5B ). It is difficult to infer the copy number from coverage depth for these six cells, which may be due to DNA degradation, inefficient cell lysis, or MALBAC amplification bias. Luckily, the predetermined haplotype information of the cell, which is less sensitive to coverage depth bias, can be used to determine the chromosome copy number for five of the six cells successfully. Besides chromosomal-level aneuploidy, the detection of missing (or duplication of) smaller DNA segments is also important, so we tried to figure out the resolution limit of this method. We observed that the normalized coverage depth curve is quite uniform (SD < 0.15) at larger than megabase resolution but gets very noisy (SD > 2.5) at resolution down to 10 kb ( Figures 5C and  S6C ). Then we estimated the sensitivity and specificity of aneuploidy detection under different resolutions using the resolved ploidy information of our oocytes as a reference. We found that both sensitivity and specificity get higher for lower resolutions, and it achieves 97.8% sensitivity and 99.5% specificity at 5 Mb resolution ( Figure 5C ). In fact, for submegabase resolution (0.5 Mb), it achieves 94.8% sensitivity and 97.5% specificity, which is superior to most available CGH and SNP array technologies (Coe et al., 2007) .
Aneuploidy in Oocytes
A primary oocyte replicates its diploid genome at prophase I, forming four copies of chromatids (4C) that are segregated in sequential two meiotic divisions to generate PB1, PB2, and FPN. To assess the possibility that aneuploidy arose from the DNA replication, we checked the sum of the chromatids in PB1, PB2, and FPN from each oocyte and found that the majority (43 out of 44) of the primary oocytes implement DNA replication with high fidelity. Surprisingly, the oocyte S0608 showed a loss of four chromatids in FPN and a loss of one chromatid in PB2, whereas no gain of chromatids was detected in PB1 ( Figure S6D ), which may be caused by the failure of DNA replication or more likely the wrong segregation of chromosomes during cell division, such as aberrant segregation of a chromosome from the whole chromosome set due to an abnormal break of the spindle (Vogt et al., 2008) .
Compared to DNA replication, chromosome segregation in oocytes is more error prone, probably due to loss of cohesions, DSBs, or other lesions during long time span of female meiosis (Kurahashi et al., 2012) . We detected 12 aneuploid oocytes from 8 donors due to abnormal chromatid segregation (Table  S6 ). The aneuploid chromosomes showed clear patterns of missing or gaining coverage depth, whereas the other chromosomes showed normal coverage depth ( Figure S6E ). The average aneuploidy rate for all of the donors is 17.6%, which is reasonable considering the relatively young ages of the donors ( Figure 5D ) (Munné et al., 2007) . In the 12 aneuploid oocytes, we detected 28 aneuploid chromosomes, among which meiosis I error rate is much higher than that of meiosis II, and numerical (whole chromosome) abnormalities are more common than structural (part of chromosome) abnormalities (Hassold et al., 2007) (Figure 5E ). Chromosomes 16 and 22 are the most common aneuploid chromosomes, which is consistent with previous reports (Pellestor et al., 2002) .
Lower Crossover Activity in Aneuploid Oocytes
Homologous recombination is pertinent for proper chromosome segregation in meiosis (Page and Hawley, 2003) , and the reduction in crossover activity of the whole gamete has been reported in abnormal sperm (Hann et al., 2011; Lu et al., 2012) . Our method is able to detect crossover and aneuploidy simultaneously, giving us the chance to study the relationship between them. We found that 26 of 28 aneuploid chromosomes do have crossovers on their sister chromatids, confirming the theory that each pair of homologous chromosomes has at least one crossover (Mets and Meyer, 2009) . The reduction of crossover activity has been reported for many trisomies (Hassold et al., 1995) , and our data also show significant reduction of crossover activity for 
For this donor, the corresponding genotypes for 11 FPNs of the oocytes, which have all the PB1, PB2, and FPN recovered and sequenced, are predicted by the haplotype deduction. The ''N'' represents the alleles that are not covered by single-cell low-depth sequencing. The underlined bases represent SNVs associated with Mendelian diseases. D represents the allele that could not be amplified by locus-specific PCR from single-cell MALBAC product. Although some SNP loci are not covered by low-depth sequencing in polar bodies, the genotype of FPN can still be accurately predicted by the haplotype information. See also Figure S5 and Table S5. aneuploid chromosomes using the same statistics method (p value 3 3 10 À4 ) ( Figure S6F ). However, these may not be all of the facts. As the crossovers between the two nondisjunction chromatids that went into the same aneuploid gamete are hard to detect from current data, the crossover rate for aneuploid chromosomes is likely to be underestimated, which contributes partially to the observed reduction in crossover activity. We compared the crossover numbers from the aneuploidy and euploidy groups on both the single-haploid-cell level and oocyte triad level and observed significantly lower crossover To correct the inefficiency of crossover detection in aneuploid chromosomes, we replaced the crossover numbers in the aneuploid chromosomes by randomly choosing one from the corresponding euploid oocytes. The process was repeated 100 times, and the p values were averaged. After correction, the significance level goes down (p value gets higher) for both the oocyte triad and gamete cell levels. See also Figure S6 and Table S6 . (legend continued on next page) activity for the aneuploidy group (t test, p = 0.006, on cell level; p = 0.04, on oocyte triad level) ( Figure 5F ). The smaller difference for the oocyte level (higher p value) may be caused by the larger average number of crossovers and thus less sensitivity to variations.
To account for the crossover detection defects in aneuploid chromosomes, we replaced the crossover count on aneuploid chromosomes by randomly choosing a counterpart from the euploid group. The p values on both the single-haploid cell and oocyte level became higher (0.043 and 0.119, averaged by 100 times bootstrapping). An alternative way to make up the detection defects is to exclude the crossover count of aneuploid chromosomes from both the aneuploidy and euploidy groups for statistical analysis ( Figure S6G ). The results of both analyses supported that the crossover activity for the aneuploid oocyte is a little lower than that of the euploid oocyte, but not so much as the previous studies reported (Bugge et al., 1998; Hassold et al., 1991) .
Deducing Aneuploidy of an Oocyte Based on Polar Body Sequencing in PGS As discussed above, aneuploidy of the FPN can be deduced with the ploidy of the first and second polar bodies without destroying the fertilized egg. Figure 6A shows the normalized read density across the 23 chromosomes of the PB1 of the oocyte S0120, in which aneuploidy is clearly seen at chromosomes 2, 16, 19, and 22. It also shows the data for the corresponding PB2 of the same oocyte, which has a partial aneuploidy at chromosome 2. We then predicted what is in the FPN by subtracting the PB1 and PB2 from 4, which is the expected total number of chromatids.
To verify the prediction, we directly sequenced the female pronucleus in the same oocyte under the consent of the donor. Indeed, the prediction is experimentally verified. As a final check, we added up the data from PB1, PB2, and the female pronucleus; the number 4 is conserved along the entire genome (Figure 6A ). This result demonstrated the proof of principle of the IVF procedure for selecting a viable fertilized egg for transfer.
To estimate the minimum sequencing depth needed to accurately detect aneuploidy in an oocyte cell, we carried out data analyses by taking a subset of the data from the three cells of oocyte S0120. The results of predicted copy number for the FPN with data amount of 3 M (million bases) (0.0013), 30 M (0.013), and 300 M (0.13) are shown in Figure 6B , and the results of PB1, PB2, and confirmed FPN are shown in Figure S7A . It is evident that sequencing data as little as 30 M (0.013) can confidently detect aneuploidy.
At submegabase resolution (0.5 Mb), there is no significant decrease in detection sensitivity when reducing the sequencing depth from 13 to 0.013 ( Figures S7B and S7C ). As aneuploidy often spans an entire chromosome, this submegabase resolution is sufficient to determine aneuploidy. The fact that a sequencing depth of only 0.013 is needed is highly desirable in order to decrease the cost of PGS in IVF (Table S7) .
Comparison with Array CGH We compared our MALBAC sequencing method with the array CGH method in accuracy for detecting aneuploidies. An eightcell-stage embryo was donated by a couple who already had one healthy baby from the same oocyte retrieval cycle and donated their remaining frozen embryos for scientific research and signed informed consent. We isolated two individual cells from the eight-cell-stage embryo and analyzed one cell with MALBAC whole-genome sequencing analysis while examining the other cell with array CGH analysis with MDA amplification. As shown in Figure 6C , at whole-genome scale, both methods can accurately detect aneuploidies. Furthermore, with as low as 0.13 sequencing depth, MALBAC sequencing results show digitized signals with much less fluctuation and higher resolution (0.5 Mb) than the array CGH result (about 2.5 Mb).
Sequencing Blastocysts with MALBAC
When disease-associated SNVs or aneuploidy might come from the father, PGD/PGS have been carried out with array CGH for blastocyst biopsy (Broman et al., 1998) . A blastocyst-stage embryo was donated by a couple with the male partner known to be a carrier of a specific genetic disease. After detection of the mutation and aneuploidy of these blastocysts by MALBAC sequencing, one of the aneuploid embryos was also analyzed by array CGH under the consent of the patient. That is, two small clumps of a few trophectoderm cells were isolated from the blastocyst-stage embryo and were analyzed by MALBAC and array CGH methods side by side, as shown in Figure 6D . Clearly, the MALBAC result is less noisy and of higher resolution.
DISCUSSION
We have successfully applied whole-genome amplification based on MALBAC to single human oocytes, extending the analyses of single human sperm cells Wang et al., 2012) . The genome coverage for a single oocyte cell when sequenced at 13 is $32%, which is higher than that reported for a single sperm cell ($20%) with comparable sequencing depth probably because of the looser chromatin structure of oocytes. Distinctly different from sperm, the oocytes exhibit several features in meiosis, such as higher recombination rates and higher aneuploidy rates, yielding the first comprehensive analyses of female meiosis recombination.
(C) Comparison of aneuploidy deduction between MALBAC sequencing and array CGH method for an eight-cell-stage embryo. Two individual cells from an aneuploid eight-cell-stage embryo were analyzed by these two independent methods. Chromosome 14 shows loss of a large segment of its long arm. The resolution is 0.5 Mb for MALBAC sequencing, whereas the resolution is 2.5 Mb for array CGH. (D) Comparison of aneuploidy deduction between MALBAC sequencing and array CGH method for a blastocyst stage embryo. Two small clumps of a few trophectoderm cells were isolated from an aneuploid blastocyst-stage embryo and analyzed by these two independent methods. There is a whole-chromosome aneuploidy for chromosome 8. The resolution is 0.5 Mb for MALBAC sequencing, whereas the resolution is about 2.5 Mb for array CGH. See also Figure S7 and Table S7 .
This study not only provides information about meiosis of human oocytes but also yields a procedure for PGS in IVF. Although more blastocyst biopsies have currently been used in PGD/PGS, the polar body biopsy has advantages when aneuploidies and disease alleles are inherited from the mother. First, the polar body biopsy is performed on the oocyte retrieval day (day 0) rather than day 5, so more time is available for sequencing and analyses, especially if freezing of embryos needs to be avoided. Second, blastocyst biopsy removes cells from the growing embryo, whereas the polar body biopsy removes genetic material that is dispensable for embryonic development. However the disadvantages for polar body biopsy are that it cannot detect the aneuploidies and mutations inherited from the father and cannot detect the aneuploidies and de novo mutations arising from mitosis.
By sequencing the first and second polar bodies, we have provided proof of principle for a low-cost PGS procedure of selecting fertilized eggs for transfer that are free of maternal aneuploidy and alleles associated with Mendelian diseases. The same method in principle can be applied to blastocysts, considering that the severe genetic variation is either from the father or the mother. Our MALBAC sequencing offers improved resolution and accuracy of simultaneous detection of chromosome abnormality and heterozygous SNVs associated with Mendelian diseases. The aneuploidy detection by next-generation sequencing is comparable or even less expensive than CGH arrays, whereas the disease SNV calling is still costly. As the sequencing costs decrease rapidly, by offering more accurate information, our single-cell amplification method will gain more advantages in the future. Such a single-cell manipulation and diagnosis allows probing and bettering of life at the single-molecule level.
EXPERIMENTAL PROCEDURES Donor Recruitment and Oocyte Retrieval
This study has been approved by the Reproductive Study Ethics Committee at Peking University Third Hospital (research license 2012SZ014). All oocytes and sperm were obtained with informed consent, which confirmed that donors voluntarily donated oocytes and sperm. All of the procedures for oocyte collection and operation were performed following standard clinical protocols (Li et al., 2008) . The oocyte donors have already had one or two healthy children from natural pregnancy, and they donated their oocytes purely for research purposes.
Isolation and MALBAC Whole-Genome Amplification of Single Polar Bodies and Pronuclei
The first polar bodies (PB1) and second polar bodies (PB2) were sequentially picked after ICSI. The male and female pronuclei were removed after the zygote entered pronuclear stage. Each single-cell sample was assigned a unique cell ID beginning with an ''S,'' followed by a four-digit number and an alphabetic letter. Suffixes of single-cell ID ''A, B, and C'' mean PB1, PB2, and FPN, respectively. Each polar body or pronucleus was transferred into individual PCR tubes and lysed in 5 ml lysis buffer. The DNA released from the lysed cell in each tube was amplified using MALBAC .
High-Throughput Sequencing and Prefiltering of the Sequencing Data
The qualified amplified genomic DNA was used to construct Illumina libraries for high-throughput sequencing. The MALBAC amplification primers, Illumina library adapters, and unreliable low-quality read ends were trimmed from the raw sequencing data.
Calling of Heterozygous SNPs for the Donor and Genotype Determination of the Oocyte Cells
The confident heterozygous SNPs for each donor were determined by integrating all the genotype likelihoods of all her oocyte cells. With the donor's heterozygous SNP information, the posterior probabilities for each SNP allele were estimated in each oocyte cell by the Bayesian theory.
Phasing Heterozygous SNPs and Inferring Genome Positions of Crossovers
The hetSNPs of the donor were phased, and the genome positions of crossovers were inferred in all oocyte cells by two independent algorithms, and these two algorithms generated largely consistent results. Additional details are provided in the Extended Experimental Procedures.
Normalization of Coverage Depth and Aneuploidy Detection
For each cell, the normalized coverage depth was calculated by dividing the averaged raw depth of several cells from the same window, as well as the sequencing depth of the given sample. Aneuploidy was identified when the observed copy number was different from the expected ones.
ACCESSION NUMBERS
The sequencing data have been deposited in the National Center for Biotechnology Information under the accession number SRA091188.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and seven tables and can be found with this article online at http://dx. doi.org/10.1016/j.cell.2013.11.040.
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